Changes in RPV Resistance-Related Mutations Among Antiretroviral Therapy-Naïve HIV-1-Positive Individuals - China, 2004-2023
{{output}}
Introduction: Rilpivirine (RPV) is currently included in first-line antiretroviral therapy (ART) regimens in China. However, the baseline RPV resistance remains unclear, especially among different HIV-1 subtypes in China. ... ...
